Logo image of LJPC

LA JOLLA PHARMACEUTICAL CO (LJPC) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:LJPC - US5034596040 - Common Stock

6.22 USD
0 (0%)
Last: 8/19/2022, 8:00:02 PM
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to LJPC. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.35. This target is 2.16% above the current price.
LJPC was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about LJPC.
In the previous month the buy percentage consensus was at a similar level.
LJPC was analyzed by 6 analysts. More opinions would make the average more meaningful.
LJPC Historical Analyst RatingsLJPC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -68 -62 -56 -50 -44 -38 -32 -26 -20 -14 -8 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 6.226.296.356.356.54 - 1.16% 2.16% 2.16% 5.17%
LJPC Current Analyst RatingLJPC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

LA JOLLA PHARMACEUTICAL CO / LJPC FAQ

What do analysts expect the price target to be for LA JOLLA PHARMACEUTICAL CO (LJPC)?

6 analysts have analysed LJPC and the average price target is 6.35 USD. This implies a price increase of 2.16% is expected in the next year compared to the current price of 6.22.


What is the consensus rating for LJPC stock?

The consensus rating for LA JOLLA PHARMACEUTICAL CO (LJPC) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


What is the number of analysts for LJPC stock?

The number of analysts covering LA JOLLA PHARMACEUTICAL CO (LJPC) is 6.